Randomized Trialhigh evidence
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
The New England journal of medicine·March 13, 2025·PMID 39665649
Why it mattersThis large, randomized trial provides high-level evidence that surgical axillary staging may be safely omitted in selected patients with early, clinically node-negative breast cancer, potentially sparing many women from lymphedema and arm dysfunction without compromising oncologic outcomes.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled